Internal Medicine • Research • Visualized VISUALIZED: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification 1 min read Read further: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification FacebookXPinterestLinkedIn
Article NL C.62(2026) • Internal Medicine Longitudinal Efficacy of Donor Microbiota Capsules in... 3 min read
Article NL C.62(2026) • Internal Medicine Transforming MIBC Therapy: Phase 3 Results of... 3 min read
Article NL C.62(2026) • Internal Medicine Transformer-Based AI System Predicts Functional... 2 min read
Article NL C.62(2026) • Internal Medicine Skin-Derived G-CSF Drives Emergency Granulopoiesis and... 2 min read